Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and organic radicals are highly reactive molecules containing oxygen or carbon with unpaired electrons, primarily generated as byproducts of mitochondrial metabolism and enzymatic activity (Sies et al., 2017). In physiological conditions, they serve as vital signaling molecules regulating cell growth, differentiation, and the immune response (Pizzino et al., 2017). However, excessive accumulation leads to oxidative stress, causing irreversible damage to DNA, proteins, and lipids, which is a key driver in the progression of chronic diseases such as cancer, Alzheimer's, and atherosclerosis (NIH, 2023). Therapeutic targeting involves the use of antioxidants and radical scavengers, such as Edaravone or N-acetylcysteine, to neutralize these species and prevent tissue damage (StatPearls, 2023). Despite their therapeutic potential, non-selective removal of ROS can interfere with necessary cellular signaling pathways, presenting a significant challenge in drug development (Halliwell, 2011). Furthermore, the use of high-dose antioxidants has occasionally been linked to increased mortality or accelerated cancer progression in specific clinical contexts.
Drugs targeting these species typically act through direct scavenging, where they donate electrons to neutralize unpaired electrons, or by acting as mimetics of endogenous antioxidant enzymes like superoxide dismutase and catalase (Sies et al., 2017).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and organic radicals (ROS) (ROS).